Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Lori D Bash"'
Publikováno v:
JMIR Perioperative Medicine, Vol 7, p e52278 (2024)
BackgroundNeuromuscular blockade (NMB) agents are a critical component of balanced anesthesia. NMB reversal methods can include spontaneous reversal, sugammadex, or neostigmine and the choice of reversal strategy can depend on various factors. Unanti
Externí odkaz:
https://doaj.org/article/738e3734784e4dbbb9133209bbf7a64f
Autor:
Amit D Raval, Sohan Deshpande, Silvia Rabar, Maria Koufopoulou, Binod Neupane, Ike Iheanacho, Lori D Bash, Jay Horrow, Thomas Fuchs-Buder
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231452 (2020)
BACKGROUND:Deep neuromuscular blockade may facilitate the use of reduced insufflation pressure without compromising the surgical field of vision. The current evidence, which suggests improved surgical conditions compared with other levels of block du
Externí odkaz:
https://doaj.org/article/b3ed48ff10a946908ddb6de124b99875
Autor:
Lori D. Bash, Kellee White, Mehul D. Patel, Jinan Liu, Panagiotis Mavros, Kenneth W. Mahaffey
Publikováno v:
Cardiology and Therapy, Vol 8, Iss 2, Pp 329-343 (2019)
Abstract Introduction Long-term risk for recurrent cardiovascular events among myocardial infarction (MI) patients in the acute versus chronic stable phase is not well characterized. This study was conducted to evaluate risk factors associated with a
Externí odkaz:
https://doaj.org/article/dd7d1e335a7f49d2a7095fa9b526c399
Autor:
Anselm K. Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M. De Ferrari, Ami Vyas, Carl A. Baxter, Lori D. Bash, Veronica Ashton, Martin Horack, Wael Almahmeed, Fu-Tien Chiang, Kian Keong Poh, Philippe Brudi, Baishali Ambegaonkar
Publikováno v:
Data in Brief, Vol 18, Iss , Pp 1937-1940 (2018)
DYSIS II CHD was a longitudinal, observational study in 6794 patients from 18 countries. They were attending an outpatient physician appointment for coronary heart disease (CHD). 6370 patients (93.8%) were on active lipid lowering therapy (LLT). The
Externí odkaz:
https://doaj.org/article/72b6ea01da3448e59793e75a6c86d0f7
Autor:
Anselm K. Gitt, Dominik Lautsch, Jean Ferrières, Gaetano M. De Ferrari, Ami Vyas, Carl A. Baxter, Lori D. Bash, Veronica Ashton, Martin Horack, Wael Almahmeed, Fu-Tien Chiang, Kian Keong Poh, Philippe Brudi, Baishali Ambegaonkar
Publikováno v:
Data in Brief, Vol 16, Iss , Pp 369-375 (2018)
DYSIS II ACS was a longitudinal, observational study in 3867 patients from 18 countries. They were being hospitalized after suffering an acute coronary syndrome. Evaluations were performed at the time of admission and again 120±15 days following the
Externí odkaz:
https://doaj.org/article/41f5b3bf196d46d2b084b17854037a2d
Autor:
Lori D. Bash, Dahlia Weitzman, Robert O. Blaustein, Ofer Sharon, Varda Shalev, Gabriel Chodick
Publikováno v:
Israel Journal of Health Policy Research, Vol 6, Iss 1, Pp 1-10 (2017)
Abstract Background Congestive heart failure (CHF) is among the most common causes of hospital admissions and readmissions in the Western world. However, the burden of ambulatory care has not been as well investigated. The objective of this study was
Externí odkaz:
https://doaj.org/article/88f76326f28744b5a288ac44f723bf66
Autor:
Massimiliano Greco, Pier Francesco Caruso, Giovanni Angelotti, Romina Aceto, Giacomo Coppalini, Nicolò Martinetti, Marco Albini, Lori D. Bash, Michele Carvello, Federico Piccioni, Roberta Monzani, Marco Montorsi, Maurizio Cecconi
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 2; Pages: 563
Background: Neuromuscular blocking agent (NMBA) monitoring and reversals are key to avoiding residual curarization and improving patient outcomes. Sugammadex is a NMBA reversal with favorable pharmacological properties. There is a lack of real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d47a2f8513456d40989b471918f5ed1
Autor:
Yejin Mok, Shoshana H. Ballew, Lori D. Bash, Deepak L. Bhatt, William E. Boden, Marc P. Bonaca, Juan Jesus Carrero, Josef Coresh, Ralph B. D'Agostino, C. Raina Elley, F. Gerry R. Fowkes, Sun Ha Jee, Csaba P. Kovesdy, Kenneth W. Mahaffey, Girish Nadkarni, Eric D. Peterson, Yingying Sang, Kunihiro Matsushita
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 14 (2018)
Background The Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention (TRS2°P), a 0‐to‐9‐point system based on the presence/absence of 9 clinical factors, was developed to classify the risk of major adverse cardiovasc
Externí odkaz:
https://doaj.org/article/754404e227834eda9d8a06e1d7a10733
Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings
Publikováno v:
Advances in Therapy
Introduction The management of neuromuscular blockade (NMB) has evolved over time and remains a critical component of general anesthesia. However, NMB use varies by patient and procedural characteristics, clinical practices, protocols, and drug acces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85b621aea33bcdef2a6036c9fd5f9449
https://doi.org/10.1007/s12325-021-01835-2
https://doi.org/10.1007/s12325-021-01835-2
Publikováno v:
Advances in Therapy
Introduction Sugammadex rapidly reverses the effects of rocuronium- and vecuronium-induced neuromuscular blockade (NMB), offering a more complete and predictable NMB recovery than cholinesterase inhibitors. Despite clinical benefits, cost pressures o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f30bcb275ba6d5117fa72d60c0f1f4cc
https://doi.org/10.1007/s12325-021-01701-1
https://doi.org/10.1007/s12325-021-01701-1